Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

NCT01845675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Advanced Well-differentiated Pancreatic Neuroendocrine Tumor

Interventions

DRUG: temozolomide or dacarbazine-based chemotherapy, endostatin

Sponsor

Peking Union Medical College Hospital